Page last updated: 2024-09-03

iguratimod and Breast Cancer

iguratimod has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Peng, G; Sun, Y; Wang, BY; Wu, YX; Ye, DW; Yu, SY; Zhang, P	1

Other Studies

1 other study(ies) available for iguratimod and Breast Cancer

Article	Year
Anti-rheumatic drug iguratimod (T-614) alleviates cancer-induced bone destruction via down-regulating interleukin-6 production in a nuclear factor-κB-dependent manner. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2016, Volume: 36, Issue:5 Topics: Animals; Apoptosis; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Carcinogenesis; Cell Movement; Cell Proliferation; Chromones; Female; Humans; Interleukin-6; MCF-7 Cells; Neoplasm Invasiveness; Rats; Sulfonamides; Transcription Factor RelA	2016

Article

Year

Anti-rheumatic drug iguratimod (T-614) alleviates cancer-induced bone destruction via down-regulating interleukin-6 production in a nuclear factor-κB-dependent manner.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2016, Volume: 36, Issue:5

Topics: Animals; Apoptosis; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Carcinogenesis; Cell Movement; Cell Proliferation; Chromones; Female; Humans; Interleukin-6; MCF-7 Cells; Neoplasm Invasiveness; Rats; Sulfonamides; Transcription Factor RelA

2016